Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5582/irdr.2016.01048 http://scihub22266oqcxt.onion/10.5582/irdr.2016.01048 C4995426!4995426!27672537     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27672537&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27672537.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Intractable+Rare+Dis+Res 2016 ; 5 (3): 145-57 Nephropedia Template TP {{tp|p=27672537|t=2016. Fragile X syndrome: A review of clinical management |pdf=|usr=}}{{27672537}} gab.com Text Fragile X syndrome: A review of clinical management JO: Intractable Rare Dis Res http://www.kidney.de/pget.php?&tw=1&pmid=27672537 #FOAvip The fragile X mental retardation 1 gene, which codes for the fragile X mental retardation 1 protein, usually has 5 to 40 CGG repeats in the 5? untranslated promoter. The full mutation is the almost always the cause of fragile X syndrome (FXS). The prevalence of FXS is about 1 in 4,000 to 1 in 7,000 in the general population although the prevalence varies in different regions of the world. FXS is the most common inherited cause of intellectual disability and autism. The understanding of the neurobiology of FXS has led to many targeted treatments, but none have cured this disorder. The treatment of the medical problems and associated behaviors remain the most useful intervention for children with FXS. In this review, we focus on the non-pharmacological and pharmacological management of medical and behavioral problems associated with FXS as well as current recommendations for follow-up and surveillance. Twit Text FOAVip Fragile X syndrome: A review of clinical management ????Intractable Rare Dis Res http://www.kidney.de/pget.php?&tw=1&pmid=27672537 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27672537 #FOAvip English Wikipedia <ref>{{Cite pmid|27672537}}</ref> Fragile X syndrome: A review of clinical management #MMPMID27672537 Lozano R; Azarang A; Wilaisakditipakorn T; Hagerman RJ Intractable Rare Dis Res 2016[Aug]; 5 (3): 145-57 PMID27672537show ga The fragile X mental retardation 1 gene, which codes for the fragile X mental retardation 1 protein, usually has 5 to 40 CGG repeats in the 5? untranslated promoter. The full mutation is the almost always the cause of fragile X syndrome (FXS). The prevalence of FXS is about 1 in 4,000 to 1 in 7,000 in the general population although the prevalence varies in different regions of the world. FXS is the most common inherited cause of intellectual disability and autism. The understanding of the neurobiology of FXS has led to many targeted treatments, but none have cured this disorder. The treatment of the medical problems and associated behaviors remain the most useful intervention for children with FXS. In this review, we focus on the non-pharmacological and pharmacological management of medical and behavioral problems associated with FXS as well as current recommendations for follow-up and surveillance. äFragile X syndrome: A review of clinical management (epmc).pdf DeepDyve Pubget Overpricing